CTKB earnings: a negative outcome, -5.6%

On November 9, 2022, Cytek Biosciences, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.6% in the window around the event. It had already run +6.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.